Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Merit Medical Systems Earnings Call: Key Takeaways

Merit Medical delivered a strong Q3 2026 beat, raising full-year guidance driven by 9% organic growth and significant operating margin expansion despite gross margin headwinds.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthUS sales up 11%; International up 3%; Foundational 8%; Therapeutic 11%.
Mgmt ConfidenceHigh confidence in meeting three-year CGI targets; raised full-year 2026 guidance.
Demand VisibilityStrong pipeline for Viewpoint; better than expected demand in primary categories.
Margin TrendsOperating margin 21.3% up 160bps; Gross margin 52.8% down 81bps.
Op. LeverageOperating expenses increased only 1% against 8% revenue growth.
Vol vs PriceGrowth driven by strong demand across foundational and therapeutic product categories.
Segment GrowthOEM up 15%; Oncology up 16%; Foundational products organic growth 8%.
New ClientsStrong pipeline of evaluations at academic institutions for Viewpoint Medical products.
Capex & DebtAcquired SoloPace for $45M; Net leverage ratio 1.5x; $505.8M cash.
RegulatoryMonitoring China VBP and potential Section 232 tariff impacts.
CommentaryFocusing on 'right to win' high-growth procedures in 2027-2029 strategic plan.
New LaunchesLaunched Scout MD in May; integrating SoloPace for TAVR procedures.

Growth

Total revenue $416M up 8%; organic growth 9%; non-GAAP EPS increased 22% year-over-year.

Outlook

Raised 2026 organic growth to 7.1%-7.6% and non-GAAP EPS to $4.33-$4.37.

Risks

Gross margins declined 81bps due to manufacturing variances, freight, and platinum costs.

Source

The company's earnings call, NASDAQ: MMSI, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Merit Medical Systems Inc: key numbers

Share price
$86.35Close, Nov 16
Market cap
$5.17B
Shares outstanding
59.92MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Merit Medical Systems Inc

All →
12:37 PM ET Form 4
Insider Selling

Merit Medical Systems CLO, Secretary Brian G. Lloyd Sells $1.44M of Stock

Brian G. Lloyd, CLO, Secretary, sold 16,722 shares of Merit Medical Systems Inc at $86.33 a share, worth $1.44M in total on Nov 16, 2026. Shares held after the trade: 60,132 (-21.8%).

Value
$1.44M
Shares
16,722
Price
$86.33
Role
CLO, Secretary
Holding change
-21.8%
Trade date
Nov 16, 2026
4:12 PM ET 10-Q
Financial Results ▶ Call

Merit Medical Systems Q3 2026 Results: Net Income $42.3M, Up 52.4% YoY

Merit Medical Systems reported net sales of $1.22 billion for the nine months ended September 30, 2026, representing an 8.5% increase over the prior year. Net income for the same period rose significantly to $122.1 million, up from $90.5 million in 2025, driven by improved gross margins and controlled operating expenses.

Key figure
Net income $42.3M · +52.4% YoY
4:08 PM ET 8-K
Financial Results

Merit Medical Systems Financial Results

Merit Medical Systems reported Q3 2026 financial results with 8.4% revenue growth and raised its full-year 2026 guidance. The company also disclosed the $45 million cash acquisition of Solo Pace, Inc., which was completed on October 13, 2026.

Counterparty
Solo Pace, Inc.

“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture.”

Martha G. Aronson, Merit’s President and CEO

“We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year.”

Martha G. Aronson, Merit’s President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.